Cooler but still well above normal this week

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Pfizer is facing a shortage of penicillin due to increased demand and more diagnoses of syphilis, the company said

The company said there is an "impending stock out situation" for select Bicillin L-A and Bicillin C-R prefilled syringes, Pfizer's brand name of injectable

Prefilled Bicillin L-A pediatric syringes are expected to begin running low by the end of June, while all Bicillin C-R syringes could begin diminishing in the third quarter of this year. 

Inventory is predicted to start recovering in the second and third quarters of 2024, Pfizer said. 

Patients and providers navigate ‘historical peak’ of drug shortages

Penicillin is an antibiotic used to treat various types of infections, including sexually transmitted diseases, such as syphilis and pneumonia.

Syphilis rates were at a historic low from 2000 to 2001, but have increased every year since, with an increase of 28.6% from 2020 to 2021, which was likely exacerbated by an interruption in treatment and prevention due to the COVID-19 pandemic, the Centers for Disease Control and Prevention said. 

a long-term shortage of prescription drugs the U.S. has been experiencing for the last decade, usually as a result of disruptions in the supply chain, like the one caused by the pandemic, Marta Wosińska, a visiting fellow at The Brookings Institution, 

Other prescriptions, such as Adderall and children's flu medication have also 

Health

Ayana Archie

Author

The shortage comes as there has been a steady increase in rates of syphilis since 2000. Inventory can start depleting as early as this month, Pfizer said. 

Pfizer warns of a looming penicillin supply shortage

Go Deeper.

Like this?

News you can use in your inbox